Wearables & Devices

Healthtech Company Asensus Surgical Announces Finalization of Name

Asensus Surgical

Effective on March 5, 2021, Asensus Surgical will trade under ticker symbol ASXC

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the formal completion of its previously announced name and ticker symbol change.

Effective today, Friday March 5, 2021, the Company’s stock will trade on the NYSE American under its new ticker symbol ASXC, and name, Asensus Surgical, Inc. The previous ticker symbol was “TRXC,” and the previous name was “TransEnterix, Inc.”

No actions are needed from current stockholders relative to the ticker symbol change.

Business Wire

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire has 18 newsrooms worldwide to meet the needs of communications professionals and news media.

Related posts

Friendly to Offer Fully Integrated Solution With Azure IoT

PR Newswire

Medical Device Company FineHeart Successfully Raises €15 million

Business Wire

Wave Neuro receives 2023 Restore Technology Award

Business Wire